These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19255896)

  • 1. The role of apolipoprotein E in uptake of atovaquone into the brain in murine acute and reactivated toxoplasmosis.
    Shubar HM; Dunay IR; Lachenmaier S; Dathe M; Bushrab FN; Mauludin R; Müller RH; Fitzner R; Borner K; Liesenfeld O
    J Drug Target; 2009 May; 17(4):257-67. PubMed ID: 19255896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood-brain barriers.
    Shubar HM; Lachenmaier S; Heimesaat MM; Lohman U; Mauludin R; Mueller RH; Fitzner R; Borner K; Liesenfeld O
    J Drug Target; 2011 Feb; 19(2):114-24. PubMed ID: 20367080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis.
    Dunay IR; Heimesaat MM; Bushrab FN; Müller RH; Stocker H; Arasteh K; Kurowski M; Fitzner R; Borner K; Liesenfeld O
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4848-54. PubMed ID: 15561866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis.
    Schöler N; Krause K; Kayser O; Müller RH; Borner K; Hahn H; Liesenfeld O
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1771-9. PubMed ID: 11353624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
    Zensi A; Begley D; Pontikis C; Legros C; Mihoreanu L; Wagner S; Büchel C; von Briesen H; Kreuter J
    J Control Release; 2009 Jul; 137(1):78-86. PubMed ID: 19285109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model.
    Re F; Cambianica I; Zona C; Sesana S; Gregori M; Rigolio R; La Ferla B; Nicotra F; Forloni G; Cagnotto A; Salmona M; Masserini M; Sancini G
    Nanomedicine; 2011 Oct; 7(5):551-9. PubMed ID: 21658472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease.
    Gormley PD; Pavesio CE; Minnasian D; Lightman S
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1171-5. PubMed ID: 9620076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.
    Gelperina S; Maksimenko O; Khalansky A; Vanchugova L; Shipulo E; Abbasova K; Berdiev R; Wohlfart S; Chepurnova N; Kreuter J
    Eur J Pharm Biopharm; 2010 Feb; 74(2):157-63. PubMed ID: 19755158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation.
    Weiss CK; Kohnle MV; Landfester K; Hauk T; Fischer D; Schmitz-Wienke J; Mailänder V
    ChemMedChem; 2008 Sep; 3(9):1395-403. PubMed ID: 18613205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ultrastructural study of the effect of treatment with atovaquone in brains of mice chronically infected with the ME49 strain of Toxoplasma gondii.
    Ferguson DJ; Huskinson-Mark J; Araujo FG; Remington JS
    Int J Exp Pathol; 1994 Apr; 75(2):111-6. PubMed ID: 8199003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells.
    Sauer I; Dunay IR; Weisgraber K; Bienert M; Dathe M
    Biochemistry; 2005 Feb; 44(6):2021-9. PubMed ID: 15697227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis.
    Sordet F; Aumjaud Y; Fessi H; Derouin F
    Parasite; 1998 Sep; 5(3):223-9. PubMed ID: 9772721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain.
    Michaelis K; Hoffmann MM; Dreis S; Herbert E; Alyautdin RN; Michaelis M; Kreuter J; Langer K
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1246-53. PubMed ID: 16554356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
    Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
    J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of recrudescent toxoplasmic encephalitis using ponazuril in an immunodeficient mouse model.
    Mitchell SM; Zajac AM; Kennedy T; Davis W; Dubey JP; Lindsay DS
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S164-5. PubMed ID: 17169046
    [No Abstract]   [Full Text] [Related]  

  • 16. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
    Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
    AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.
    Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
    Eur J Pharm Biopharm; 2008 Sep; 70(1):75-84. PubMed ID: 18472255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of atovaquone and pyrrolidine dithiocarbamate in the treatment of acute murine toxoplasmosis.
    Djurković-Djaković O; Nikolić A; Bobić B; Klun I
    Chemotherapy; 2004 Jun; 50(3):155-6. PubMed ID: 15272229
    [No Abstract]   [Full Text] [Related]  

  • 20. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction.
    Wang H; Durham L; Dawson H; Song P; Warner DS; Sullivan PM; Vitek MP; Laskowitz DT
    Neuroscience; 2007 Feb; 144(4):1324-33. PubMed ID: 17187933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.